|
Schedules:
|
ISNR 18th Annual Conference
|
Omni Interlocken Resort |
Thank You to our Sponsors |
Keynote Speakers:
Norman Doidge, MD
Norman Doidge, M.D., is a psychiatrist, psychoanalyst, researcher, author, essayist and poet. He is on the Research Faculty at Columbia University's Center for Psychoanalytic Training and Research, in New York, and the University of Toronto's Department of Psychiatry.
Dr. Doidge served as Head of the Psychotherapy Centre and the Assessment Clinic at the Clarke Institute of Psychiatry, and taught in the departments of Philosophy, Political Science, Law and Psychiatry at the University of Toronto. He has published on trauma, problems in love, psychiatric diagnoses and intensive psychotherapies, and is the author of standards and guidelines for the practice of intensive psychotherapy that are widely used in Canada. In 1993 he presented his early research at the White House in Washington, D.C., and is credited with helping preserve these treatments as part of the Canadian and Australian health care systems. He is a Training Analyst (a trainer of psychoanalysts) in the Canadian Institute of Psychoanalysis. Dr. Doidge has won a number of scientific awards, including the U.S. National Psychiatric Endowment Award in Psychiatry; the American Psychoanalytic Association's CORST Prize in Psychoanalysis and Culture; the Canadian Psychoanalytic Association's M. Prados Prize; and election to the American College of Psychoanalysts for "many outstanding achievements in psychiatry and psychoanalysis... and national leadership in psychiatry." He was recently awarded the Mary S. Sigourney Prize, the highest award in international psychoanalysis, and the National Association of Mental Illness Ken Book Award. He is a reviewer for the Harvard Review of Psychiatry.
Jonathan Marks, MA, BCL
Jonathan H. Marks is Associate Professor of Bioethics, Humanities and Law at the Pennsylvania State University. He is Director of the bioethics program at the main campus, University Park, and has a joint appointment in the College of Medicine at Hershey. He is also a barrister and founding member of Matrix Chambers, London. Jonathan was counsel for Human Rights Watch in the Pinochet case, and represented Dr. Nancy Olivieri in the European Court of Justice-a landmark case on pharmaceutical regulation. The Olivieri case vividly demonstrated the potential hazards to academic independence presented by industry-sponsored medical research and triggered Jonathan's interest in bioethics and, in particular, his interest in situational and systemic threats to ethical conduct. Jonathan received his M.A., B.C.L. (equivalent to J.D., LL.M.) from Oxford University and, from 2004-6, he was a Greenwall Fellow in Bioethics and Health Policy at the Johns Hopkins Bloomberg School of Public Health and Georgetown University Law Center. Jonathan has published widely on the legal and ethical implications of the use of health professionals, behavioral science and neuroscience in interrogation. His work on this topic has appeared in the New England Journal of Medicine, American Journal of Law and Medicine, New York Times, the American Journal of Bioethics: Neuroscience and the Hastings Center Report (among others). n August 2009, Jonathan Marks was named the Edmond J. Safra Faculty Fellow in Ethics at Harvard University, where he will be on leave until June 2011.
.
Alvaro Pascual-Leone, MD, PhD
Dr. Pascual-Leone is the Director of the Center for Non-Invasive Brain Stimulation and Professor of Neurology at Harvard Medical School and the Beth Israel Deaconess Medical Center in Boston.
Dr. Pascual-Leone is Board Certified in Neurology and Neurophysiology by the American Board of Psychiatry and Neurology. His focus is to understand neural plasticity at system's level. He seeks to identify rules that are invariant across neural systems and domains. He believe that plasticity is the normally ongoing state of the nervous system and that a coherent account of any neurocognitive theory and neural system has to contemplate plasticity as an integral property of the nervous system and the obligatory consequence of each sensory input, motor act, association, reward signal, action plan, or awareness. In this framework, notions such as psychological processes as distinct from organic-based functions or dysfunctions, or of "good" and "bad" plasticity, cease to be informative. Plasticity is the reason for development and learning, the cause of disease, and a mechanism of functional recovery. The challenge is to learn enough about the mechanisms of plasticity in order to manipulate them, suppressing some changes and enhancing others, to gain a clinical benefit and behavioral advantage for a given individual.
In the laboratory Dr. Pascual-Leone combines various brain imaging and neurophysiologic methodologies to establish a causal relationship and a precise chronometry between regional brain activation and behavior. PET or fMRI identify information about brain areas associated with behavior. TMS can transiently deactivate a region of the brain, thus creating a "virtual patient" and explore causal relations. EEG, MEG and ERPs can provide further chronometric information. Repetitive TMS and tDCS allow the non-invasive modulation of activity in a specified cortical target area and its functionally connected cortico-subcortical neural network. MRI and EEG can guide such applications of neuromodulation. Such non-invasive approaches can lead to clinically relevant therapeutic effects in neuropsychiatry and neurorehabilitation, and serve as proof-of-principle prior to more invasive neuromodulatory interventions.
Invited Speakers:
Donald Cooper, PhD
Donald Cooper received his PhD in Neuroscience from the Chicago Medical School in 2000. Dr. Cooper is the recipient of an NIH career award to investigate gene expression in cocaine addiction. His laboratory is funded by the NIH to study Ecstasy and cocaine in the brain memory and reward system.
The long-term goals of Dr. Cooper's laboratory are to understand information processing in the brain motivation/reward memory circuitry and characterize the adaptations and impaired neural memory mechanisms associated with depression, addiction and schizophrenia.
Dr. Cooper's neurophysiology laboratory combines behavioral, molecular genetic and detailed electrophysiological analysis to understand how psychostimulant drugs alter neuronal impulse activity leading to short and long-term changes in communication within mesolimbic dopamine system. Their approach to this problem utilizes state-of-the-art technology (e.g. DNA microarrays, viral gene transduction, infrared and fluorescence visualized patch-clamp physiology and intravenous drug self-administration) and complementary levels of analysis (e.g. drug self-administration, in vivo and in vitro physiology, molecular techniques and computer simulation) in order to gain insight into how this system functions under normal and pathological conditions.
Dirk DeRidder, MD
Professor Dirk De Ridder is a neurosurgeon, working in Antwerp, Belgium, whose research is focused on the pathophysiology and treatment of phantom perceptions. He developed the technique of electrical auditory cortex stimulation for tinnitus and somatosensory cortex stimulation for pain and recently for auditory hallucinations as well. His expertise extends beyond tinnitus and he is additionally investigating a diversity of clinical populations with a variety of neuroimaging techniques and neuromodulatory interventions.
Hartmut Heinrich, PhD
Hartmut Heinrich received his PhD from the University of Heidelberg. His thesis was "Wavelet analysis methods in a study on attention deficit / hyperactivity disorder". Since 2003 he has been the head of the working group "Neurophysiology in child & adolescent psychiatry" at the Dept. of Child & Adolescent Psychiatry, University of Erlangen and Heckscher-Klinik in Munich, Germany.
Matthew Nock, PhD
Matthew Nock, PhD, is an associate professor in the Experimental Psychopathology and Clinical program at Harvard University. He received his PhD in psychology from Yale University in 2003 and joined the faculty at Harvard that same year.
Dr. Nock's research interests are broad and focus primarily on the etiology, assessment, and treatment of self-injurious (e.g., suicide and self-mutilation) and aggressive behaviors, particularly among children and adolescents. Current projects include the development and evaluation of laboratory and ecological assessment methods for evaluating processes associated with self-injurious and aggressive behaviors. A related line of research focuses on the evaluation of treatments for impulsive, aggressive, and self-injurious behaviors and the factors that mediate and moderate clinical change in treatment. His ISNR presentation will be on Single-Case Experimental Designs: A Practical but Unassailable Methodology for Neurofeedback Research in Clinical Practice.
Paul Rapp, PhD
Paul Rapp attended the University of Illinois as a James Scholar. He received a Bachelors degree in Physiology (minor in Chemistry) and a second Bachelors degree in Engineering Physics in 1972. He then attended Cambridge University as a Churchill Scholar and received his Ph.D. in 1975. His doctoral work, under the supervision of Professor Sir James Lighthill, was conducted in the Department of Applied Mathematics and Theoretical Physics. Following graduation he was elected to a Fellowship at Gonville and Caius College, Cambridge. During this period he continued teaching in the Faculty of Mathematics and performed combined theoretical and experimental work in collaboration with Professor Sir Michael Berridge in the Invertebrate Chemistry and Physiology Unit at Cambridge. This work led to the publication of the calcium-cyclic nucleotide oscillator hypothesis. He joined the faculty of the Medical College of Pennsylvania in 1979.
At present, Rapp is a Professor of Military and Emergency Medicine at the Uniformed Services University and Director of the Traumatic Injury Research Program. He also holds a secondary appointment as a Professor of Medical and Clinical Psychology. Previously he was a Professor of Pharmacology and Physiology at Drexel University College of Medicine (the successor organization to the Medical College of Pennsylvania) and Director of Research at the Clinical Research Center at Norristown State Hospital.
Professor Rapp is a Candidate at the Philadelphia School of Psychoanalysis and has practiced as a psychotherapist at the Philadelphia Consultation Center. He is a past editor of Physica, and is currently on the editorial boards of the International Journal of Bifurcation and Chaos, Chaos and Complexity Letters, and Cognitive Neurodynamics. Past honors include a Certificate of Commendation from the Central Intelligence Agency for "significant contributions to the mission of the Office of Research and Development.
Jason Soss, MD
Jason R. Soss is a staff neurologist and Assistant Professor of Neurology at UCLA School of Medicine. He is trained as an epileptologist specializing in dense array monitoring and intracranial recording, and is engaged in a variety of EEG research studies.
Dr. Soss completed a fellowship in Neurology at UCLA School of Medicine in 2002, a residency in Neurology at the University of Michigan Health System, and earned his medical degree from Thomas Jefferson University in Philadelphia. He is a Diplomate of the National Board of Medical Examiners, and Board certified in Clinical Neurophysiology and in Neurology. His research includes localization of seizure onset through nonlinear analysis of scalp EEG and physiologic mechanisms of epilepsy. Past research was funded by the Epilepsy Foundation of America and the National Epifellows Foundation. He is a graduate of Yale University.Clinical Neurophysiology.
Michael A. Schmidt, PhD
Michael A. Schmidt, Ph.D. did his Ph.D. research in molecular medicine and biochemistry within the Life Sciences Division at NASA Ames Research Center, and also did a fellowship in NASA's Psychophysiology Research Laboratory. Dr. Schmidt has done additional studies in neuroscience and metabolomics at Lancaster University (UK). He continues to work in collaboration with NASA in the areas of metabolism and human performance. Dr. Schmidt is the author of Brain-Building Nutrition: How Dietary Fats and Oils Affect Mental, Physical and Emotional Intelligence and Beyond Antibiotics: Strategies for Living in a World of Emerging Infections and Antibiotic-Resistant Bacteria. In addition to his neuroplasticity research, his work is centered on applying metabolomics, functional genomics, systems biology, and informatics to human disease and performance. He is the founder of Sovaris Aerospace, focused on space biomedicine and biotechnology.
Letter from the Conference Chair:
It is with great pleasure that I welcome you to an ISNR conference for the third year as the conference chair. For this 18th Annual International Conference of the International Society for Neurofeedback and Research I am delighted to host you in Denver, Colorado, one of the few cities in history that was not built on a road, railroad, lake, navigable river or body of water when it was founded. It just happened to be where the first few flakes of gold were found in 1858. ISNR, like Denver, has grown from golden ideas and holds a bright and rich future. With this spirit I invite you to join in a collective reflection on what our field has accomplished during these past 18 years, and on the scholarly challenges before us.
In addition to the parallel oral presentations, panel sessions, and workshops, here are a few highlights of the plenary sessions:
- Keynote Speaker- Norman Doidge, MD, NY Times best-selling author, will present "The Brain That Changes Itself: The Neuroplasticity Revolution and Film Clips of People Undergoing Plastic Change"
- Keynote Speaker- Alvaro Pascual-Leone, MD, PhD- "Multimodal Brain Imaging: Combining Brain Stimulation and Functional Neuroimaging to Understand A Changing Brain"
- Keynote Speaker- Jonathan Marks, MA, BCL- "Beyond Neurotherapy: The Ethics of National Security Neuroscience"
Invited Speakers:
- Dirk DeRidder, MD, PhD – "Alcohol Addiction: A Clinical Pathophysiological Approach"
- Matthew Nock, PhD – "Single-Case Experimental Design: A Valuable Method for Evaluating Neurofeedback in Clinical Practice"
- Hartmut Heinrich, PhD – "Theta / Beta and SCP Training in Children with Attention-Deficit/Hyperactivity Disorder: Behavioral and Neurophysiological Results from a Randomized Controlled Trial"
- Michael Schmidt, PhD – "Nutrient Modifiers of Neuroplasticity and Performance and the Exploration of Novel QEEG Assessment Metrics"
- Donald Cooper, PhD – "Single Cell Memory: How individual Neurons Route and Store Temporary Information to Maintain Attention"
- Paul Rapp, PhD – "Could Neurofeedback Reconstruct Synchronous Networks Lost Following Traumatic Brain Injury?"
- Jason Soss, MD- " Neural Network Mapping"
As in our previous conferences, you can expect the opportunities to network with a diversity of colleagues from a variety of institutions. On Wednesday, there will the ISNR golf tournament with a portion of the proceeds going to the ISNR Research Foundation. The tournament and Wednesday pre-conference workshops will be followed by an evening reception and our now traditional special panel Neurofeedback: The Past, Present and Future from the "Pioneering Women's Perspective" featuring Genie Bodenhamer-Davis, PhD, Judith Lubar, MSW, and Lynda Thompson, PhD.
On Thursday evening, there will be a reception during the poster presentations and a first time evening plenary session. Our conference wouldn't be complete without a Saturday evening presentation of honors, dinner and entertainment this year by Swing Essence, where attendees will enjoy conversation and dining with live jazz that you would expect in the finest clubs, featuring a jazz-inspired rhythm section, and accomplished instrumentalists.
During the past few years, the ISNR conference has achieved steady growth as evident from the support received from professionals, academia and industry. I would like to express sincere thanks to all the presenters and the members of the conference committee that has made this event a success. Also I would like to thank Deymed Diagnostic (Platinum), BrainMaster (Gold) and Nova Tech EEG, Thought Technology and Stens Corporation (Silver) for their sponsorship of the conference. Because of all of your efforts, the conference program is very rich with exciting papers and events.
Finally, I hope that you will find the presentations and discussions to be a valuable resource in your professional, research, and educational activities whether you are a student, academic, researcher, or a practicing professional. I encourage you to take part in this international conference, and I very much look forward to welcoming you personally to Denver in September!
Leslie Sherlin, PhD
2010 Conference Chair